STAT9d
In debate over obesity medications, FDA shifts toward importance of drugs in subtle ways
The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...
STAT4d
Demoting BMI, a new food label from the FDA, and risks of even moderate drinking
An international group of experts proposes two new categories of disease: preclinical and clinical obesity and the FDA ...
FDA proposes warning label on front of food packaging to combat obesity epidemic
Packaged foods may soon have warning labels about how much sodium, saturated fats, and added sugars they contain in an effort ...
Today's Dietitian magazine4h
Some Racial and Ethnic Groups May Face Barriers to Obtaining Obesity Medications
Asians, non-Hispanic Blacks and Hispanics were significantly less likely than whites to use obesity-management medications to lower their weight compared with whites, new research suggests. The ...
Lilly oral obesity drug could get FDA okay in early 2026: report
CEO Dave Ricks said Monday that the company's GLP-1 weight-loss pill orforglipron could receive FDA approval as soon as early ...
BioSpace12d
FDA Proposes Setting Bar for Weight-Loss Therapies as Obesity Space Heats Up
In a rare move, the FDA recommended a minimum of 5% weight-loss for drug developers seeking to establish the efficacy of ...
FDA issues draft guidance on developing weight loss drugs
New FDA draft guidance for drugmakers focuses on trial design for developing obesity treatments. Read more here.
Say Bye to Just BMI: Experts Call for a Major Shift in How We Measure Obesity
An international and widely supported group of experts is pushing doctors to avoid the exclusive use of BMI to decide whether ...
FDA Approves Weight-loss Drug Zepbound For Sleep Apnea – Will Insurance Cover This $1000-Per-Month Medication?
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
clinicaltrialsarena5h
Novo Nordisk’s high-dose Wegovy increases weight loss and remains safe
Novo Nordisk's high dose Wegovy (semaglutide) has shown improved weight loss while remaining safe and tolerable.
Washington Examiner6d
FDA proposes warning label on front of food packaging to combat obesity epidemic
Sen. Bernie Sanders (I-VT) proposed in February 2024 that the FDA place warning labels about the risk of developing Type 2 diabetes or obesity on foods with high saturated fat, added sugar ...
Seeking Alpha7d
Lilly oral obesity drug could get FDA okay in early 2026: report
Eli Lilly (NYSE:LLY) CEO Dave Ricks said Monday that the company's GLP-1 weight-loss pill orforglipron could receive FDA approval as soon as early 2026. In an interview with Bloomberg TV ...